Although mutations in p53 have been reported to be 20–50% in human osteosarcoma[5], a recent study has found that over 90% of osteosarcomas have either sequence mutations or structural variations (mainly in the first intron) in the p53 gene[6]. The gene discussed is TP53; the disease is osteosarcoma.